These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34128255)
1. Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis. El Mansouri AE; Oubella A; Dânoun K; Ahmad M; Neyts J; Jochmans D; Snoeck R; Andrei G; Morjani H; Zahouily M; Lazrek HB Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100146. PubMed ID: 34128255 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents. El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs. El Mansouri AE; Maatallah M; Ait Benhassou H; Moumen A; Mehdi A; Snoeck R; Andrei G; Zahouily M; Lazrek HB Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1088-1107. PubMed ID: 32397827 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
5. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers. Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase. Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S J Biomol Struct Dyn; 2024 Jul; 42(11):5841-5857. PubMed ID: 37529915 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents. El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety. Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930 [TBL] [Abstract][Full Text] [Related]
11. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation. Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents. Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861 [TBL] [Abstract][Full Text] [Related]
13. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents. Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles. Caneschi W; Enes KB; Carvalho de Mendonça C; de Souza Fernandes F; Miguel FB; da Silva Martins J; Le Hyaric M; Pinho RR; Duarte LM; Leal de Oliveira MA; Dos Santos HF; Paz Lopes MT; Dittz D; Silva H; Costa Couri MR Eur J Med Chem; 2019 Mar; 165():18-30. PubMed ID: 30654237 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity. Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215 [TBL] [Abstract][Full Text] [Related]
19. New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis. Khan I; Ganapathi T; Rehman MM; Shareef MA; Kumar CG; Kamal A Bioorg Med Chem Lett; 2021 Jul; 44():128094. PubMed ID: 33964437 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]